Ali Mirebrahimi-Tafreshi, M.D
NPI 1295860732 · Internal Medicine Physician · Vienna, VA
Enrolled with Medicare as Practitioner - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1295860732
- Entity type
- Individual
- Primary specialty
- Internal Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D
- Sex
- Male
- Sole proprietor
- No
- License
- D0066508 (MD)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
748 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 270 | $142 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 112 | $101 |
| Detection Test By Immunoassay Technique for Severe Acute Respiratory Syndrome Coronavirus87426 | 99 | $35 |
| Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804 | 58 | $16 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 56 | $123 |
| Detection Test By Immunoassay With Direct Visual Observation for Streptococcus, Group a (strep) |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Azithromycin | 51 | 47 |
| Prednisone | 38 | 34 |
| Losartan Potassium | 30 | 14 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 24 | 19 |
| Triamcinolone Acetonide | 21 | — |
| Atorvastatin Calcium | 18 | 12 |
| Rosuvastatin Calcium | 18 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$116 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-02-23
- Last updated
- 2010-10-27
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.